1-10 of 10
Richard K. Dodge
Close
Sort by
Journal Articles

Sequential multiagent chemotherapy is not superior to high-dose cytarabine alone as postremission intensification therapy for acute myeloid leukemia in adults under 60 years of age: Cancer and Leukemia Group B Study 9222

Clinical Trials & Observations
Joseph O. Moore, Stephen L. George, Richard K. Dodge, Philip C. Amrein, Bayard L. Powell, Jonathan E. Kolitz, Maria R. Baer, Frederick R. Davey, Clara D. Bloomfield, Richard A. Larson, Charles A. Schiffer
Journal: Blood
Blood (2005) 105 (9): 3420–3427.
https://doi.org/10.1182/blood-2004-08-2977
Published: 2005
Journal Articles

Differences in prognostic factors and outcomes in African Americans and whites with acute myeloid leukemia

Clinical Trials & Observations
Mikkael A. Sekeres, Bercedis Peterson, Richard K. Dodge, Robert J. Mayer, Joseph O. Moore, Edward J. Lee, Jonathan Kolitz, Maria R. Baer, Charles A. Schiffer, Andrew J. Carroll, James W. Vardiman, Frederick R. Davey, Clara D. Bloomfield, Richard A. Larson, Richard M. Stone, for the Cancer and Leukemia Group B (CALGB)
Journal: Blood
Blood (2004) 103 (11): 4036–4042.
https://doi.org/10.1182/blood-2003-09-3118
Published: 2004
Journal Articles

Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461): Presented in part at the 43rd annual meeting of the American Society of Hematology, Orlando, FL, December 10, 2001, and published in abstract form. 59

Clinical Trials & Observations
John C. Byrd, Krzysztof Mrózek, Richard K. Dodge, Andrew J. Carroll, Colin G. Edwards, Diane C. Arthur, Mark J. Pettenati, Shivanand R. Patil, Kathleen W. Rao, Michael S. Watson, Prasad R. K. Koduru, Joseph O. Moore, Richard M. Stone, Robert J. Mayer, Eric J. Feldman, Frederick R. Davey, Charles A. Schiffer, Richard A. Larson, Clara D. Bloomfield
Journal: Blood
Blood (2002) 100 (13): 4325–4336.
https://doi.org/10.1182/blood-2002-03-0772
Published: 2002
Journal Articles

Phase 3 study of the multidrug resistance modulator PSC-833 in previously untreated patients 60 years of age and older with acute myeloid leukemia: Cancer and Leukemia Group B Study 9720

Clinical Trials & Observations
Maria R. Baer, Stephen L. George, Richard K. Dodge, Kieran L. O'Loughlin, Hans Minderman, Michael A. Caligiuri, John Anastasi, Bayard L. Powell, Jonathan E. Kolitz, Charles A. Schiffer, Clara D. Bloomfield, Richard A. Larson
Journal: Blood
Blood (2002) 100 (4): 1224–1232.
https://doi.org/10.1182/blood.V100.4.1224.h81602001224_1224_1232
Published: 2002
Journal Articles

Postremission therapy in older patients with de novo acute myeloid leukemia: a randomized trial comparing mitoxantrone and intermediate-dose cytarabine with standard-dose cytarabine

Clinical Trials & Observations
Richard M. Stone, Deborah T. Berg, Stephen L. George, Richard K. Dodge, Paolo A. Paciucci, Philip P. Schulman, Edward J. Lee, Joseph O. Moore, Bayard L. Powell, Maria R. Baer, Clara D. Bloomfield, Charles A. Schiffer
Journal: Blood
Blood (2001) 98 (3): 548–553.
https://doi.org/10.1182/blood.V98.3.548
Published: 2001
Journal Articles

High frequency of immunophenotype changes in acute myeloid leukemia at relapse: implications for residual disease detection (Cancer and Leukemia Group B Study 8361)

Maria R. Baer, Carleton C. Stewart, Richard K. Dodge, Gail Leget, Norbert Sulé, Krzysztof Mrózek, Charles A. Schiffer, Bayard L. Powell, Jonathan E. Kolitz, Joseph O. Moore, Richard M. Stone, Frederick R. Davey, Andrew J. Carroll, Richard A. Larson, Clara D. Bloomfield
Journal: Blood
Blood (2001) 97 (11): 3574–3580.
https://doi.org/10.1182/blood.V97.11.3574
Published: 2001
Journal Articles

Prospective Karyotype Analysis in Adult Acute Lymphoblastic Leukemia: The Cancer and Leukemia Group B Experience

Meir Wetzler, Richard K. Dodge, Krzysztof Mrózek, Andrew J. Carroll, Ramana Tantravahi, AnneMarie W. Block, Mark J. Pettenati, Michelle M. Le Beau, Stanley R. Frankel, Carleton C. Stewart, Ted P. Szatrowski, Charles A. Schiffer, Richard A. Larson, Clara D. Bloomfield
Journal: Blood
Blood (1999) 93 (11): 3983–3993.
https://doi.org/10.1182/blood.V93.11.3983
Published: 1999
Journal Articles

Value of Immunophenotype in Intensively Treated Adult Acute Lymphoblastic Leukemia: Cancer and Leukemia Group B Study 8364

Myron S. Czuczman, Richard K. Dodge, Carleton C. Stewart, Stanley R. Frankel, Frederick R. Davey, Bayard L. Powell, Ted P. Szatrowski, Charles A. Schiffer, Richard A. Larson, Clara D. Bloomfield
Journal: Blood
Blood (1999) 93 (11): 3931–3939.
https://doi.org/10.1182/blood.V93.11.3931
Published: 1999
Journal Articles

A Randomized Controlled Trial of Filgrastim During Remission Induction and Consolidation Chemotherapy for Adults With Acute Lymphoblastic Leukemia: CALGB Study 9111

Richard A. Larson, Richard K. Dodge, Charles A. Linker, Richard M. Stone, Bayard L. Powell, Edward J. Lee, Philip Schulman, Frederick R. Davey, Stanley R. Frankel, Clara D. Bloomfield, Stephen L. George, Charles A. Schiffer
Journal: Blood
Blood (1998) 92 (5): 1556–1564.
https://doi.org/10.1182/blood.V92.5.1556
Published: 1998
Journal Articles

Granulocyte Colony-Stimulating Factor (Filgrastim) Accelerates Granulocyte Recovery After Intensive Postremission Chemotherapy for Acute Myeloid Leukemia With Aziridinyl Benzoquinone and Mitoxantrone: Cancer and Leukemia Group B Study 9022

Joseph O. Moore, Richard K. Dodge, Philip C. Amrein, Jonathan Kolitz, Edward J. Lee, Bayard Powell, Scott Godfrey, Francisco Robert, Charles A. Schiffer
Journal: Blood
Blood (1997) 89 (3): 780–788.
https://doi.org/10.1182/blood.V89.3.780
Published: 1997